Filing Flows › Vera Therapeutics (VERA) › Recalls, complaints & regulation
Vera Therapeutics (VERA): clinical trials
Vera Therapeutics (VERA) beyond its filings: 4 active clinical trials.
Vera Therapeutics' latest quarter
Vera Therapeutics, Q3 2026: revenue $10.3M, operating margin -931.2%, net loss $93.7M, operating cash flow −$99.2M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Vera Therapeutics have?
4 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.